Efficacy and Safety Study of Velaglucerase Alfa in Children and Adolescents With Type 3 Gaucher Disease

Clinical trial NCT01685216 · COMPLETED

Trial details

NCT number: NCT01685216
Sponsor: Shire
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gaucher Disease, Type 3

Start date: 2012-09-14
Primary completion: 2015-03-15
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.